Catamaran Corp (CCT.TO) Buy, Sell or Hold

Catamaran Corp (CCT.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

9 watching

HOLD

Likes what they are doing from an execution point of view. Will be listed on NASDAQ and thinks the US investors will like the story.

TOP PICK

Provide software services to pharmacies. Have been providing a nice return of late. Numbers are very strong and continue to look strong going forward. Very popular product, both in Canada and the US.

BUY

Systems Excellence has good earnings. It has done well over the last year. It is a good opportunity. One of his top ten holdings. Ranks 16 in the database. It should survive even if we have a market pull back.

TOP PICK

A defensive play in that 90% of their backlogs is recurring. They are in the software and service business, managing prescription benefit programs. Got into a new business about a year ago giving more into the pharmaceutical system. There is a US law on January 1 that will be a boon to this company.

TOP PICK

The company is interesting. They provide software to pharmacies to streamline their operations. The company has jusy got a big contract. Earnings will be $0.09 this year and $0.13 next year.

BUY ON WEAKNESS

Ranks highly his database. Earnings are expected to go from $0.11 to $0.15, a 21% earnings growth. Against a 15 P/E gives you a .8 P/E to growth. If the market pulls back you may be able to buy it below $2.

DON'T BUY

Has disappointed him in the past and seems to do this all the time. Recent results don't look very good to him. Made a lot of acquisitions, but earnings are not that good.

PAST TOP PICK

(A Top Pick Nov 19/03. Down 37%.) Sold off some time ago. Company is fairly sound and has cash.

TOP PICK

Technology stock valuations have come down a lot and is a sector that still has potential to grow. Trades around 11 X forward earnings which is pretty cheap. They are going to double their earnings from last year's. Likes the health care sector that they are in. Revenue model is going more to a transactional basis rather than license.

DON'T BUY

Ranks borderline of the bottom 1/3 of the database. Earnings estimates have been revised downward. 12 PE overall for reasonable are ROE of 21%.

BUY

Likes management. As an interesting land package in Chile. Speculative.

WAIT

Expect the stock won't do a lot until they do a major acquisition along with a finance. Well-run.

BUY

Dropped because of speculation in the market that they were going to do an acquisition. Likes management. Have good revenue and are growing reasonably.

WAIT

About mid-point in the database. The large contract they have, runs out of steam the middle of this year.

DON'T BUY

Not a big fan of medical tech system companies. Stocks had big run. Wouldn't buy at this level.

Showing 106 to 120 of 143 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

John Zechner

J. Zechner & Assoc

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Catamaran Corp (CCT.TO)